ImmPACT-Bio

ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. Its technology addresses the need to differentiate cancerous from non-cancerous tissues with a special focus on a common mechanism for tumor immune-escape.